LANXESS Aktiengesellschaft

SWX:LXS Stock Report

Market Cap: CHF 1.6b

LANXESS Valuation

Is LXS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of LXS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: LXS (CHF19.2) is trading below our estimate of future cash flow value (CHF71.62)

Significantly Below Future Cash Flow Value: LXS is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for LXS?

Key metric: As LXS is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for LXS. This is calculated by dividing LXS's market cap by their current revenue.
What is LXS's PS Ratio?
PS Ratio0.3x
Sales€5.89b
Market Cap€1.80b

Price to Sales Ratio vs Peers

How does LXS's PS Ratio compare to its peers?

The above table shows the PS ratio for LXS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.6x
CLN Clariant
0.7x1.78%CHF 2.8b
VETN Vetropack Holding
0.6x2.48%CHF 490.6m
EMSN EMS-CHEMIE HOLDING
7.7x3.36%CHF 15.0b
SIGN SIG Group
1.6x1.34%CHF 4.8b
LXS LANXESS
0.3x1.63%CHF 1.8b

Price-To-Sales vs Peers: LXS is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (2.6x).

Historical Price to Sales Ratio

Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Sales Ratio vs Industry

How does LXS's PS Ratio compare vs other companies in the European Chemicals Industry?

22 CompaniesPrice / SalesEstimated GrowthMarket Cap
LXS 0.3xIndustry Avg. 1.0xNo. of Companies23PS012345+
22 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: LXS is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is LXS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LXS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate LXS's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LXS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 19.20
CHF 17.73
-7.65%
24.36%CHF 27.41CHF 12.79n/a16
Feb ’27n/a
CHF 17.05
0%
27.64%CHF 27.50CHF 9.17n/a16
Jan ’27n/a
CHF 18.00
0%
32.26%CHF 31.65CHF 9.31n/a15
Dec ’26n/a
CHF 18.87
0%
30.18%CHF 31.60CHF 9.29n/a15
Nov ’26n/a
CHF 22.77
0%
23.25%CHF 35.25CHF 15.77n/a15
Oct ’26n/a
CHF 24.13
0%
21.83%CHF 35.54CHF 15.90n/a15
Sep ’26n/a
CHF 24.71
0%
19.95%CHF 35.57CHF 15.91n/a15
Aug ’26n/a
CHF 25.55
0%
18.93%CHF 35.44CHF 18.65n/a15
Jul ’26n/a
CHF 26.01
0%
21.17%CHF 37.37CHF 18.68n/a16
Jun ’26n/a
CHF 26.06
0%
21.36%CHF 37.36CHF 18.03n/a17
May ’26n/a
CHF 26.39
0%
22.77%CHF 38.00CHF 18.07n/a17
Apr ’26n/a
CHF 28.89
0%
20.08%CHF 39.10CHF 19.07n/a15
Mar ’26n/a
CHF 26.86
0%
18.57%CHF 34.64CHF 18.73n/a16
Feb ’26n/a
CHF 26.96
0%
18.33%CHF 35.00CHF 18.92n/a16
Jan ’26n/a
CHF 26.88
0%
19.51%CHF 35.41CHF 18.64n/a16
Dec ’25n/a
CHF 26.88
0%
19.51%CHF 35.41CHF 18.64n/a16
Nov ’25n/a
CHF 28.62
0%
20.16%CHF 39.45CHF 19.72n/a17
Oct ’25n/a
CHF 27.25
0%
19.90%CHF 39.42CHF 19.71n/a18
Sep ’25CHF 56.20
CHF 26.83
-52.26%
19.98%CHF 40.13CHF 20.06n/a18
Aug ’25CHF 56.20
CHF 27.50
-51.07%
19.24%CHF 40.60CHF 20.30n/a18
Jul ’25CHF 56.20
CHF 27.48
-51.10%
18.53%CHF 40.73CHF 20.36n/a19
Jun ’25CHF 56.20
CHF 28.39
-49.49%
17.97%CHF 41.53CHF 20.76n/a19
May ’25CHF 56.20
CHF 27.52
-51.04%
17.41%CHF 41.06CHF 20.53n/a19
Apr ’25CHF 56.20
CHF 27.32
-51.39%
18.58%CHF 40.81CHF 20.40n/a19
Mar ’25CHF 56.20
CHF 26.82
-52.29%
18.93%CHF 39.29CHF 19.64n/a18
Feb ’25CHF 56.20
CHF 26.89
-52.16%
18.93%CHF 39.39CHF 19.70n/a18
CHF 17.9
Fair Value
7.3% overvalued intrinsic discount
16
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/12 04:20
End of Day Share Price 2026/02/12 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

LANXESS Aktiengesellschaft is covered by 38 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James KnightBarclays
Anil ShenoyBarclays
Andres Castanos-MollorBerenberg